Want to join the conversation?
$ADSK's total subscriptions annualized recurring revenue, or ARR, rose 15% as of Oct. 31, 2015 from last year, primarily due to a 100% increase in New Model ARR driven by desktop license subscriptions and flexible enterprise offerings. Also contributing to rise was growth in Maintenance ARR, which rose 6% from last year.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.